Enamel Matrix Derivative in Non-surgical Periodontal Treatment
Study Details
Study Description
Brief Summary
The aim of the study is to investigate the effect of enamel matrix derivative in addition to scaling and root planing in comparison to scaling and root planing only in periodontitis patients that have already undergone initial periodontal therapy and are in periodontal maintenance.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
Enamel matrix derivative (EMD) have already been widely applied as a regenerative bio-modulator in periodontal surgery and have been demonstrated to enhance periodontal regeneration. Recently, also its flapless, non-surgical application has been shown to have beneficial effects when applied during initial therapy of periodontitis.
The present study is designed as a single-blinded randomized controlled clinical trial. We plan to include a total of 50 periodontitis patients that have already undergone initial periodontal therapy, but still show remaining sites with increased periodontal probing depth (PPD). Patients will be randomly allocated at a 1:1 ratio to either scaling and root planing (SRP) in combination with EMD application into the affected pockets (test group, n=25) or to SRP only (control group, n=25). Before treatment, as well as after 3, 6 and 12 months, we plan to assess site-specific periodontal parameters as well as whole-mouth oral hygiene indices. Furthermore, we intend to evaluate gingival crevicular fluid, as well as parameters representing periodontal disease activity.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Emdogain® FL Non-surgical periodontal therapy in terms of scaling and root planing will be applied at sites with remaining periodontal pockets at reevaluation. EDTA gel will be applied for 2 minutes in the respective pockets, followed by rinsing with saline, drying and application of Emdogain® FL. |
Device: Emdogain® FL
Emdogain® FL is an enamel matrix derivative intended for subgingival and topical application in conjunction with scaling and root planing procedures to provide regeneration of tooth support lost due to periodontal disease. Emdogain® FL has been shown to be effective in residual pockets with probing depths from 5mm to 9mm with no furcation involvement in patients with adequate plaque control. Emdogain® FL has also been shown to enhance the early healing of periodontal soft tissue wounds resulting from the instrumentation of periodontal pockets.
|
| Placebo Comparator: Control group Non-surgical periodontal therapy in terms of scaling and root planing will be applied at sites with remaining periodontal pockets at reevaluation, followed by rinsing with saline. |
Other: Scaling and root planing
Scaling and root planing procedures as part of non-surgical periodontal therapy involves mechanical removal of dental plaque and calculus using curettes and sonic scalers.
|
Outcome Measures
Primary Outcome Measures
- Periodontal probing depth (PPD) [At baseline]
Distance from the gingival margin to the base of the pocket with a calibrated periodontal probe
- Periodontal probing depth (PPD) [After 3 months]
Distance from the gingival margin to the base of the pocket with a calibrated periodontal probe
- Periodontal probing depth (PPD) [After 6 months]
Distance from the gingival margin to the base of the pocket with a calibrated periodontal probe
- Periodontal probing depth (PPD) [After 12 months]
Distance from the gingival margin to the base of the pocket with a calibrated periodontal probe
Secondary Outcome Measures
- CAL (mm) [At baseline, after 3, 6 and 12 months]
CAL (Clinical attachment level): the probing depth and the distance from the gingival margin to the CEJ API: Approximal plaque index PBI: Papillary Bleeding Index PESA:Periodontal Epithelial Surface Area PISA: periodontal inflamed surface area GCF: Gingival crevicular fluid
- API, PBI (%) [At baseline, after 3, 6 and 12 months]
API: Approximal plaque index PBI: Papillary Bleeding Index
- PESA, PISA (mm2) [At baseline, after 3, 6 and 12 months]
PESA:Periodontal Epithelial Surface Area PISA: periodontal inflamed surface area
- GCF markers for periodontal regeneration [At baseline, after 3, 6 and 12 months]
GCF: Gingival crevicular fluid
- Periodontal bacteria [At baseline, after 3, 6 and 12 months]
Microbiologic evaluation of GCF via polymerase chain reaction (PCR) DNA probe test kit
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Periodontitis stage III
-
Patients that have completed initial periodontal therapy, and have remaining periodontal pockets of ≥6mm up to 9mm PPD
-
Given written informed consent form for participation in the study
Exclusion Criteria:
-
Systemic antibiotics within the previous 3 months
-
Pregnant or breastfeeding women
-
Any current or past clinically significant pathology/disease (comorbidity) that, in the opinion of the periodontists, might confound the results or poses an additional risk to the subject during participation in the study, such as renal insufficiency, malignancy, rheumatoid osteoarthritis, human immunodeficiency syndrome.
-
Patients with at least one tooth of mobility grade 0 or 1 and/or furcation involvement grade 0 or I according to Hamp
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | University Clinic of Dentistry Vienna | Vienna | Austria | 1090 |
Sponsors and Collaborators
- Medical University of Vienna
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 1248/2020